REGN logo

REGN Cash and cash equivalents

annual cash & cash equivalents:

$2.49B-$241.80M(-8.86%)
December 31, 2024

Summary

  • As of today (June 4, 2025), REGN annual cash & cash equivalents is $2.49 billion, with the most recent change of -$241.80 million (-8.86%) on December 31, 2024.
  • During the last 3 years, REGN annual cash & cash equivalents has fallen by -$397.40 million (-13.77%).
  • REGN annual cash & cash equivalents is now -19.89% below its all-time high of $3.11 billion, reached on December 31, 2022.

Performance

REGN Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNbalance sheet metrics

quarterly cash & cash equivalents:

$3.09B+$602.00M(+24.19%)
March 31, 2025

Summary

  • As of today (June 4, 2025), REGN quarterly cash & cash equivalents is $3.09 billion, with the most recent change of +$602.00 million (+24.19%) on March 31, 2025.
  • Over the past year, REGN quarterly cash & cash equivalents has increased by +$488.20 million (+18.76%).
  • REGN quarterly cash & cash equivalents is now -21.09% below its all-time high of $3.92 billion, reached on March 31, 2023.

Performance

REGN quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

REGN Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-8.9%+18.8%
3 y3 years-13.8%-7.6%
5 y5 years+53.8%+39.9%

REGN Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-19.9%at low-21.1%+60.9%
5 y5-year-19.9%+53.8%-21.1%+114.9%
alltimeall time-19.9%>+9999.0%-21.1%>+9999.0%

REGN Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$3.09B(+24.2%)
Dec 2024
$2.49B(-8.9%)
$2.49B(+23.7%)
Sep 2024
-
$2.01B(+4.7%)
Jun 2024
-
$1.92B(-26.2%)
Mar 2024
-
$2.60B(-4.7%)
Dec 2023
$2.73B(-12.1%)
$2.73B(+26.8%)
Sep 2023
-
$2.15B(+11.1%)
Jun 2023
-
$1.94B(-50.5%)
Mar 2023
-
$3.92B(+26.1%)
Dec 2022
$3.11B(+7.6%)
$3.11B(-11.0%)
Sep 2022
-
$3.49B(+2.8%)
Jun 2022
-
$3.40B(+1.5%)
Mar 2022
-
$3.35B(+15.9%)
Dec 2021
$2.89B(+31.5%)
$2.89B(-15.9%)
Sep 2021
-
$3.43B(+65.6%)
Jun 2021
-
$2.07B(+44.1%)
Mar 2021
-
$1.44B(-34.5%)
Dec 2020
$2.19B(+35.6%)
$2.19B(+39.5%)
Sep 2020
-
$1.57B(-21.0%)
Jun 2020
-
$1.99B(-9.8%)
Mar 2020
-
$2.21B(+36.5%)
Dec 2019
$1.62B(+10.2%)
$1.62B(+16.8%)
Sep 2019
-
$1.38B(+32.5%)
Jun 2019
-
$1.05B(-38.8%)
Mar 2019
-
$1.71B(+16.4%)
Dec 2018
$1.47B(+80.6%)
$1.47B(+34.9%)
Sep 2018
-
$1.09B(+18.5%)
Jun 2018
-
$917.88M(-10.0%)
Mar 2018
-
$1.02B(+25.4%)
Dec 2017
$812.70M(+51.8%)
$812.70M(+2.6%)
Sep 2017
-
$792.07M(+6.4%)
Jun 2017
-
$744.31M(-8.3%)
Mar 2017
-
$811.77M(+51.7%)
Dec 2016
$535.20M(-33.9%)
$535.20M(-41.8%)
Sep 2016
-
$920.36M(+42.4%)
Jun 2016
-
$646.51M(+7.0%)
Mar 2016
-
$604.21M(-25.3%)
Dec 2015
$809.10M(+24.7%)
$809.10M(+23.6%)
Sep 2015
-
$654.59M(+67.6%)
Jun 2015
-
$390.55M(-23.1%)
Mar 2015
-
$507.91M(-21.7%)
Dec 2014
$648.72M(+21.1%)
$648.72M(+0.3%)
Sep 2014
-
$646.55M(+7.7%)
Jun 2014
-
$600.13M(+29.9%)
Mar 2014
-
$461.86M(-13.8%)
Dec 2013
$535.61M(+132.6%)
$535.61M(+103.5%)
Sep 2013
-
$263.21M(-31.0%)
Jun 2013
-
$381.68M(+111.6%)
Mar 2013
-
$180.36M(-21.7%)
Dec 2012
$230.28M(-52.4%)
$230.28M(+93.5%)
Sep 2012
-
$119.00M(-30.8%)
Jun 2012
-
$171.94M(-56.4%)
Mar 2012
-
$394.58M(-18.4%)
Dec 2011
$483.61M(+329.6%)
$483.61M(+134.3%)
Sep 2011
-
$206.40M(-18.8%)
Jun 2011
-
$254.31M(+87.9%)
Mar 2011
-
$135.38M(+20.3%)
Dec 2010
$112.57M(-45.6%)
$112.57M(-65.4%)
Sep 2010
-
$325.29M(+190.4%)
Jun 2010
-
$112.00M(-4.5%)
Mar 2010
-
$117.31M(-43.3%)
Dec 2009
$207.07M(-16.4%)
$207.07M(-17.3%)
Sep 2009
-
$250.32M(-7.8%)
Jun 2009
-
$271.47M(+36.3%)
Mar 2009
-
$199.10M(-19.7%)
Dec 2008
$247.80M
$247.80M(-21.3%)
Sep 2008
-
$314.68M(+7.7%)
Jun 2008
-
$292.13M(-43.9%)
DateAnnualQuarterly
Mar 2008
-
$520.88M(+4.4%)
Dec 2007
$498.93M(+109.7%)
$498.93M(+412.2%)
Sep 2007
-
$97.42M(-11.2%)
Jun 2007
-
$109.64M(-29.9%)
Mar 2007
-
$156.48M(-34.2%)
Dec 2006
$237.88M(+28.9%)
$237.88M(+41.9%)
Sep 2006
-
$167.66M(+45.8%)
Jun 2006
-
$114.96M(-37.0%)
Mar 2006
-
$182.33M(-1.2%)
Dec 2005
$184.51M(+93.8%)
$184.51M(+4.8%)
Sep 2005
-
$176.09M(+21.3%)
Jun 2005
-
$145.20M(-1.8%)
Mar 2005
-
$147.82M(+55.2%)
Dec 2004
$95.23M(-19.5%)
$95.23M(-9.3%)
Sep 2004
-
$105.05M(-14.5%)
Jun 2004
-
$122.83M(-29.4%)
Mar 2004
-
$174.03M(+47.1%)
Dec 2003
$118.28M(+47.7%)
$118.28M(-60.4%)
Sep 2003
-
$298.62M(+130.3%)
Jun 2003
-
$129.66M(-32.3%)
Mar 2003
-
$191.59M(+139.3%)
Dec 2002
$80.08M(-67.6%)
$80.08M(+6.0%)
Sep 2002
-
$75.57M(+8.9%)
Jun 2002
-
$69.37M(-48.8%)
Mar 2002
-
$135.47M(-45.2%)
Dec 2001
$247.39M(+698.6%)
$247.39M(+147.5%)
Sep 2001
-
$99.97M(-30.1%)
Jun 2001
-
$142.96M(-22.1%)
Mar 2001
-
$183.62M(+492.7%)
Dec 2000
$30.98M(+30.7%)
$30.98M(-37.6%)
Sep 2000
-
$49.64M(-39.3%)
Jun 2000
-
$81.75M(+565.0%)
Mar 2000
-
$12.29M(-48.1%)
Dec 1999
$23.70M(+19.7%)
$23.70M(+0.9%)
Sep 1999
-
$23.50M(+14.1%)
Jun 1999
-
$20.60M(-5.5%)
Mar 1999
-
$21.80M(+10.1%)
Dec 1998
$19.80M(-31.5%)
$19.80M(-12.4%)
Sep 1998
-
$22.60M(+0.4%)
Jun 1998
-
$22.50M(+16.6%)
Mar 1998
-
$19.30M(-33.2%)
Dec 1997
$28.90M(-16.2%)
$28.90M(-28.3%)
Sep 1997
-
$40.30M(-21.6%)
Jun 1997
-
$51.40M(+84.2%)
Mar 1997
-
$27.90M(-19.1%)
Dec 1996
$34.50M(+5.5%)
$34.50M(-8.0%)
Sep 1996
-
$37.50M(-23.3%)
Jun 1996
-
$48.90M(+310.9%)
Mar 1996
-
$11.90M(-63.6%)
Dec 1995
$32.70M(+38.6%)
$32.70M(+454.2%)
Sep 1995
-
$5.90M(-64.9%)
Jun 1995
-
$16.80M(+32.3%)
Mar 1995
-
$12.70M(-46.2%)
Dec 1994
$23.60M(+88.8%)
$23.60M(+54.2%)
Sep 1994
-
$15.30M(-15.0%)
Jun 1994
-
$18.00M(+125.0%)
Mar 1994
-
$8.00M(-36.0%)
Dec 1993
$12.50M(-23.8%)
$12.50M(-68.5%)
Sep 1993
-
$39.70M(+402.5%)
Jun 1993
-
$7.90M(-21.8%)
Mar 1993
-
$10.10M(-38.4%)
Dec 1992
$16.40M(-37.4%)
$16.40M(-14.6%)
Sep 1992
-
$19.20M(-12.7%)
Jun 1992
-
$22.00M(-11.6%)
Mar 1992
-
$24.90M(-5.0%)
Dec 1991
$26.20M(+20.2%)
$26.20M(-25.1%)
Sep 1991
-
$35.00M(-10.7%)
Jun 1991
-
$39.20M(+79.8%)
Dec 1990
$21.80M
$21.80M

FAQ

  • What is Regeneron Pharmaceuticals annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals annual cash & cash equivalents year-on-year change?
  • What is Regeneron Pharmaceuticals quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals quarterly cash & cash equivalents year-on-year change?

What is Regeneron Pharmaceuticals annual cash & cash equivalents?

The current annual cash & cash equivalents of REGN is $2.49B

What is the all time high annual cash & cash equivalents for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high annual cash & cash equivalents is $3.11B

What is Regeneron Pharmaceuticals annual cash & cash equivalents year-on-year change?

Over the past year, REGN annual cash & cash equivalents has changed by -$241.80M (-8.86%)

What is Regeneron Pharmaceuticals quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of REGN is $3.09B

What is the all time high quarterly cash & cash equivalents for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high quarterly cash & cash equivalents is $3.92B

What is Regeneron Pharmaceuticals quarterly cash & cash equivalents year-on-year change?

Over the past year, REGN quarterly cash & cash equivalents has changed by +$488.20M (+18.76%)
On this page